The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX(*D)
Last

(U.S.) $0.30

Today's change0.00 -0.20%
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX(*D)
Last

(U.S.) $0.30

Today's change0.00 -0.20%
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc down (U.S.)$0.00

Repros Therapeutics Inc closed lower Tuesday, dropping (U.S.)$0.00 or 0.20% to (U.S.)$0.30. Over the last five days, shares have lost 2.89% and are down 77.59% for the last year to date. This security has underperformed the S&P 500 by 102.05% during the last year.

Key company metrics

  • Open(U.S.) $0.30
  • Previous close(U.S.) $0.30
  • High(U.S.) $0.31
  • Low(U.S.) $0.29
  • Bid / Ask(U.S.) $0.29 / (U.S.) $0.30
  • YTD % change-77.59%
  • Volume105,809
  • Average volume (10-day)408,858
  • Average volume (1-month)384,097
  • Average volume (3-month)686,176
  • 52-week range(U.S.) $0.26 to (U.S.) $2.28
  • Beta0.37
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.63
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2644
Selling / general / administrative1442
Research & development1102
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-6-4-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-6-4-4
Income after tax-2-6-4-4
Income tax, total--------
Net income-2-6-4-4
Total adjustments to net income--------
Net income before extra. items-2-6-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-6-4-4
Inc. avail. to common incl. extra. items-2-6-4-4
Diluted net income-2-6-4-4
Dilution adjustment--------
Diluted weighted average shares28262624
Diluted EPS excluding extraordinary itemsvalue per share-0.08-0.22-0.16-0.17
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.08-0.22-0.16-0.17